Suppr超能文献

特比萘芬与克霉唑治疗足癣的比较。

Comparison of terbinafine and clotrimazole in treating tinea pedis.

作者信息

Evans E G, Dodman B, Williamson D M, Brown G J, Bowen R G

机构信息

Department of Microbiology, University of Leeds and General Infirmary.

出版信息

BMJ. 1993 Sep 11;307(6905):645-7. doi: 10.1136/bmj.307.6905.645.

Abstract

OBJECTIVE

To compare the efficacy and safety of terbinafine 1% cream and clotrimazole 1% cream in the treatment of tinea pedis.

DESIGN

Multicentre, double blind parallel group study.

SETTING

32 general practices and one hospital.

PATIENTS

256 patients with mycologically confirmed tinea pedis. Of the 211 patients evaluable, 107 were randomised to terbinafine (75 male, 32 female; mean (range) age 40 (12-81) years) and 104 to clotrimazole (79 male, 25 female; mean (range) age 36 (12-71) years).

INTERVENTIONS

Terbinafine 1% cream applied twice daily for one week and inert cream applied twice daily for the next three weeks. Clotrimazole 1% cream applied twice daily for four weeks.

MAIN OUTCOME MEASURES

Mycological cure (negative results on microscopy and culture) and effective treatment (mycological cure plus no or minimal signs and symptoms) measured at weeks 1, 2, 3, 4, and 6.

RESULTS

At week four rates of mycological cure were 93.5% for terbinafine and 73.1% for clotrimazole (p = 0.0001); and at week six 97.2% for terbinafine and 83.7% for clotrimazole (p = 0.001). Rates of effective treatment at week 4 were 89.7% for terbinafine and 58.7% for clotrimazole (p = 0.0001); and 89.7% for terbinafine and 73.1% for clotrimazole (p = 0.002) at week 6.

CONCLUSION

These results indicate that a one week course of terbinafine 1% cream is more effective in the treatment of tinea pedis than a four week course of clotrimazole 1% cream, both in terms of mycological cure and effective treatment.

摘要

目的

比较1%特比萘芬乳膏和1%克霉唑乳膏治疗足癣的疗效和安全性。

设计

多中心、双盲平行组研究。

地点

32家普通诊所和1家医院。

患者

256例经真菌学确诊的足癣患者。在211例可评估患者中,107例被随机分配至特比萘芬组(男75例,女32例;平均(范围)年龄40(12 - 81)岁),104例被随机分配至克霉唑组(男79例,女25例;平均(范围)年龄36(12 - 71)岁)。

干预措施

1%特比萘芬乳膏每日涂抹两次,连用一周,接下来三周每日涂抹惰性乳膏。1%克霉唑乳膏每日涂抹两次,连用四周。

主要观察指标

在第1、2、3、4和6周时评估真菌学治愈(显微镜检查和培养结果为阴性)和有效治疗(真菌学治愈加无或仅有轻微体征和症状)情况。

结果

在第4周时,特比萘芬组的真菌学治愈率为93.5%,克霉唑组为73.1%(p = 0.0001);在第6周时,特比萘芬组为97.2%,克霉唑组为83.7%(p = 0.001)。在第4周时,特比萘芬组的有效治疗率为89.7%,克霉唑组为58.7%(p = 0.0001);在第6周时,特比萘芬组为89.7%,克霉唑组为73.1%(p = 0.002)。

结论

这些结果表明,就真菌学治愈和有效治疗而言,1%特比萘芬乳膏一周疗程治疗足癣比1%克霉唑乳膏四周疗程更有效。

相似文献

引用本文的文献

1
Antimicrobial Peptide Synergies for Fighting Infectious Diseases.抗菌肽协同作用对抗感染性疾病。
Adv Sci (Weinh). 2023 Sep;10(26):e2300472. doi: 10.1002/advs.202300472. Epub 2023 Jul 5.
4
Topical treatments for fungal infections of the skin and nails of the foot.足部皮肤和指甲真菌感染的局部治疗方法。
Cochrane Database Syst Rev. 2007 Jul 18;2007(3):CD001434. doi: 10.1002/14651858.CD001434.pub2.

本文引用的文献

1
Mechanisms of action of the antimycotic imidazoles.抗真菌咪唑类药物的作用机制
J Invest Dermatol. 1981 Jun;76(6):438-41. doi: 10.1111/1523-1747.ep12521036.
4
In vitro activity of terbinafine.特比萘芬的体外活性。
Clin Exp Dermatol. 1989 Mar;14(2):101-3. doi: 10.1111/j.1365-2230.1989.tb00901.x.
5
Treatment of tinea cruris with topical terbinafine.外用特比萘芬治疗股癣
J Am Acad Dermatol. 1990 Oct;23(4 Pt 2):800-4. doi: 10.1016/0190-9622(90)70292-p.
9
Mechanisms of action of retinoic acid in skin repair.维甲酸在皮肤修复中的作用机制。
Br J Dermatol. 1992 Sep;127 Suppl 41:21-4. doi: 10.1111/j.1365-2133.1992.tb16983.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验